Stay updated on Zephyrus II Pamrevlumab Clinical Trial

Sign up to get notified when there's something new on the Zephyrus II Pamrevlumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zephyrus II Pamrevlumab Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The 403 error page has been replaced by the full ClinicalTrials.gov researcher record for Zephyrus II, with study results, design, eligibility criteria, recruitment status, and administrative details.
    Difference
    59%
    Check dated 2026-11-08T01:36:32.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T20:14:37.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A notice announces an NIH terminology transition, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-24T22:21:51.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T22:22:27.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:15:23.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The Researcher view now renders a 403 Forbidden error page, replacing the study details. This indicates an access restriction or server issue that prevents viewing the NCT04419558 record.
    Difference
    21%
    Check dated 2026-09-19T20:22:41.000Z thumbnail image

Stay in the know with updates to Zephyrus II Pamrevlumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zephyrus II Pamrevlumab Clinical Trial page.